miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.

MLA

Jiang, Ze-Bin, et al. “MiR-365 Inhibits the Progression of Gallbladder Carcinoma and Predicts the Prognosis of Gallbladder Carcinoma Patients.” Cell Cycle, vol. 20, no. 3, Feb. 2021, pp. 308–19. EBSCOhost, https://doi.org/10.1080/15384101.2021.1874694.

APA

Jiang, Z.-B., Ma, B.-Q., Feng, Z., Liu, S.-G., Gao, P., & Yan, H.-T. (2021). miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients. Cell Cycle, 20(3), 308–319. https://doi.org/10.1080/15384101.2021.1874694

Chicago

Jiang, Ze-Bin, Bing-Qiang Ma, Zongfeng Feng, Shao-Guang Liu, Peng Gao, and Hui-Ting Yan. 2021. “MiR-365 Inhibits the Progression of Gallbladder Carcinoma and Predicts the Prognosis of Gallbladder Carcinoma Patients.” Cell Cycle 20 (3): 308–19. doi:10.1080/15384101.2021.1874694.